GSK: from treatment to prevention for healthy ageing
September 24, 2024 | 18:44
Dr. Pham Thi My Lien, president of GSK Vietnam, spoke with VIR’s Bich Thuy about the importance of adult vaccinations, one of the most effective interventions contributing to improved quality of life, reducing the burden on healthcare, the economy, and society.
Pharmaceutical players seek expansion of rights in Vietnam
July 31, 2024 | 16:19
While continuing to make positive business results in Vietnam’s pharma market in the first half of 2024, multinationals are seeking an expansion of their rights.
COPD treatment is of utmost importance
May 22, 2024 | 09:31
Professor Paul Jones, emeritus professor of Respiratory Medicine at St George’s University of London, shared his perspectives on COPD.
GSK Vietnam and EPLUS partner to increase access to new vaccines
July 08, 2023 | 15:17
GSK Vietnam and EPLUS Research JSC have signed an MoU to bring the latest innovations in medicines and vaccines to Vietnam.
The UK continues celebrating successes in healthcare sector in Vietnam
March 17, 2023 | 09:00
The UK Prime Minister’s Trade Envoy to Vietnam, Mark Garnier, on March 15 visited GSK's warehouse in Ho Chi Minh City during his first official visit to the Southeast Asian nation.
Pharma giants gaining big in 2022
August 10, 2022 | 14:00
International pharma giants have reported strong results for the first half of 2022, with new plans in the pipeline from many of them in this country.
Sanofi and GSK to seek regulatory authorisation for COVID-19 vaccine
March 02, 2022 | 09:51
Sanofi and GSK on February 23 announced that they intend to submit data from both their booster and phase 3 efficacy trials as the basis for regulatory applications for a COVID-19 vaccines.
Post COVID-19: Burden doubles as childhood immunisations are disrupted
November 04, 2021 | 14:58
Due to COVID-19, tens of millions of children have missed out on life-saving vaccines, threatening the risk of outbreaks of diseases.
US health behemoths cater to fresh demand
October 21, 2021 | 08:00
US giants like General Electric, GSK, Merck, and Johnson & Johnson are eyeing new projects in Vietnam’s health sector to tap into local growing healthcare spending, signaling heated competition ahead in the lucrative market.
Healthcare for the disadvantaged
February 25, 2021 | 10:00
GSK is cooperating with Save the Children to improve basic healthcare services and access for ethnic minorities in Vietnam.
Pharma groups redouble patient-centric efforts
January 27, 2021 | 08:00
Driven by 2020’s highlights, international pharma giants are planning to deliver more vital medicines and vaccines to Vietnam in 2021 to tap into local demands and enable the country to weather future crises.
GSK withdraws HIBERIX in Vietnam due to low demand
December 15, 2020 | 16:41
GlaxoSmithKline (GSK) has decided to discontinue HIBERIX in Vietnam due to low medical demand for this vaccine and follow the Pharmaceutical Law.
Popular pharma products withdrawn by multinationals
December 10, 2020 | 10:00
Multinationals like Sanofi, GSK, Adamed Pharma, and Merck Sharp & Dohme have requested marketing authorisation withdrawal of some pharmaceuticals, with it being unclear if the quality of some popular items is an underlying issue.
Partnership signed to fight against antimicrobial resistance in Vietnam in 2021-2023
November 29, 2020 | 21:31
The Medical Service Administration, the British Embassy, and the Representative Office of GSK will fight against antimicrobial resistance in 2021-2023.
Digitalisation prompts evolution of healthcare
September 04, 2020 | 15:00
Burning to take advantage of Vietnam’s new digital transformation in the healthcare sector, international pharma giants like Novartis, AstraZeneca, Sanofi, and GSK are working to align with the new requirements and obtain sustainable gains.
1 2
Mobile Version